Latham Named Among Top Foreign Firms in India in 2023
IBLJ recognized Latham for standout work in capital markets, financing, healthcare, and technology matters.
Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs.
Latham’s cross-disciplinary healthcare and life sciences team delivers insightful, practical guidance and sophisticated representation to a full spectrum of companies across the globe, on every type of transaction or dispute a company may face. Many of us hold advanced scientific degrees and have served in senior positions as government regulators, C-Suite executives in leading healthcare and life sciences companies, as well as serving as primary outside counsel for key industry associations.
We regularly navigate commercial and regulatory issues related to the Food and Drug Administration, the Patent Trial and Appeals Board, the European Medicines Agency, the European Commission, and other state, and federal agencies in the US and across Europe.
We deliver:
IBLJ recognized Latham for standout work in capital markets, financing, healthcare, and technology matters.
Firm advises on award-winning deal announced at Singapore Venture & Private Capital Association Awards.
Healthcare and life sciences licensing and corporate deal teams advised on the transaction recognized for innovative industry collaboration.